| Schedule of Segment Expenses |
Schedule
of Segment Expenses
| (In thousands) | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended
September 30, | | |
For the Nine Months Ended
September 30, | |
| (In thousands) | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Research and Development: | |
| | | |
| | | |
| | | |
| | |
| Employee expense | |
$ | 1,420 | | |
$ | 1,329 | | |
$ | 3,767 | | |
$ | 4,028 | |
| Clinical | |
| 1,233 | | |
| 859 | | |
| 2,747 | | |
| 2,691 | |
| Product | |
| 143 | | |
| 251 | | |
| 333 | | |
| 799 | |
| Other | |
| 80 | | |
| 146 | | |
| 216 | | |
| 515 | |
| Total research and development | |
| 2,876 | | |
| 2,585 | | |
| 7,063 | | |
| 8,033 | |
| Selling, General and Administrative Expense: | |
| | | |
| | | |
| | | |
| | |
| Employee expense | |
| 743 | | |
| 1,251 | | |
| 2,703 | | |
| 4,795 | |
| Professional fees | |
| 396 | | |
| 335 | | |
| 1,145 | | |
| 1,224 | |
| Reserve for (recovery of) uncollectible prepaid clinical costs | |
| - | | |
| (291 | ) | |
| - | | |
| 335 | |
| Occupancy | |
| 164 | | |
| 165 | | |
| 483 | | |
| 480 | |
| Insurance | |
| 150 | | |
| 146 | | |
| 440 | | |
| 466 | |
| Other | |
| 205 | | |
| 692 | | |
| 558 | | |
| 1,553 | |
| Total selling, general and administrative expense | |
| 1,658 | | |
| 2,298 | | |
| 5,329 | | |
| 8,853 | |
| Loss from Operations | |
| 4,534 | | |
| 4,883 | | |
| 12,392 | | |
| 16,886 | |
| Adjustments and reconciling items | |
| (167 | ) | |
| (344 | ) | |
| (576 | ) | |
| (1,150 | ) |
| Net Loss | |
$ | 4,367 | | |
$ | 4,539 | | |
$ | 11,816 | | |
$ | 15,736 | |
|